Eye injection trial aims to halt rare childhood blindness disease
NCT ID NCT03940690
Summary
This study tested whether injections into the eye (anti-VEGF) could control Coats disease, a rare condition that causes abnormal blood vessels and fluid buildup in the retina, often leading to vision loss. It aimed to see if these injections, used alone or with other treatments, could improve the disease stage better than standard care. The trial was designed for patients with moderate Coats disease who had not yet received any treatment for their affected eye.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL TELANGIECTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bordeaux
Bourdeaux, 33076, France
-
CHU de Reims
Reims, France, 51092, France
-
Centre hospitalier René Dubos (Pontoise)
Cergy-Pontoise, France, 95303, France
-
Clinique Rive Gauche
Toulouse, France, 31000, France
-
Fondation Ophtalmologique A. de Rothschild
Paris, France, 75019, France
-
Hôpital Universitaire Necker Enfants Malades, APHP
Paris, France, 75015, France
Conditions
Explore the condition pages connected to this study.